The mission to improve

patient care


patient outcomes

Prostate cancer will affect 1 in 7 men. 1 The standards for screening and biopsy blindly sample the prostate without knowing where the cancer is, if any. We’re here to set a new standard of care with MRI-targeted fusion biopsies.

Focal Healthcare is a world-class medical device company dedicated to improving the physician and patient experience from prostate cancer diagnosis to treatment.

Meet the Fusion Bx

The Fusion Bx’s semi-robotic arm allows the probe to be maneuvered effortlessly, while maintaining consistent pressure on the prostate. With a freehand-like motion and minimal prostate deformation, the Fusion Bx enables you to accurately locate and target suspicious regions of interest.

bx arm extended
Play Video about bx arm extended

A few guiding principles

Good design starts with form and function. Great design embodies the principles upon which it is built. Informed by our end users, our products are designed around three key pillars:


Compared to ultrasound imaging, MRI can be considered the “Gold Standard” for detecting lesions. MRI-targeted biopsies with Fusion Bx addresses potential sources of inaccuracy during biopsy procedures by targeting 3 key areas: prostate deformation, patient motion and registration.


Innovative technology doesn’t need to be complicated. Driven by end users, our 4-step guided workflow and semi-robotic arm eases the procedure for both physicians and patients.


Through rigorous testing and a fine attention to detail, we’ve developed a quality cost effective solution for fusion biopsies. Thoughtful engineering, multi-probe compatibility and accommodating customer service makes our system accurate, efficient and accessible to everyone. 

Fusion 101

Fusion biopsy technology combines previously taken MRIs with live ultrasound to improve the visibility of suspicious lesions in the prostate. This allows physicians to take fewer cores because lesions can now be targeted. Get to know more about fusion and the Fusion Bx.


For Physicians

Fusion Bx strikes the optimal balance between accuracy and efficiency. 

For Patients

Fusion Bx provides meaningful and actionable results with fewer biopsies.

Let us tell you more

Email us for more information and we’ll start the conversation.

Distributor Series: QT Instruments Pte Ltd
QT Instruments is a medical technology and instrument distributor specializing in nuclear science. Owned by Biomedia, the company has been providing turnkey solutions to…
top geal
Distributor Series: Top Geal Co., Ltd.
Top Geal is a medical equipment distributor specializing in dental and, more recently, urological imaging. Based in Taipei, the company has been serving the…
quantib prostate x FHC
Quantib® Prostate Now Integrates with Focal Healthcare’s Fusion Bx
Now compatible with the Fusion Bx, Quantib® Prostate is an FDA cleared and CE marked AI-based software that is here to make the growing…

1 Statistics – Prostate Cancer Canada. (n.d.). Retrieved from

2 Cookson, M. S., MD, & Stratton, K. L., MD. (2018, April 10). Point: Is MRI fusion biopsy the new gold standard for diagnosis?Urology Times. Retrieved from